Ozempic maker Novo Nordisk reports 62% surge in profit

Novo Nordisk on Wednesday said its fourth-quarter profit surged by nearly two-thirds, driven by the popularity of its weight-loss drugs that have made it Europe’s largest company.Novo Nordisk NVO, said its profit rose 62% to 21.96 billion kroner ($3.19 billion), as sales climbed 37% to 65.86 billion kroner. Its operating profit came in 5% ahead of a company-compiled consensus, while sales were 4% ahead of estimates.Novo Nordisk shares NOVO.B, +1.54% rose 2% in early Copenhagen trade, and the stock has soare ...